Abstract:Background: Endocrine-disrupting chemicals (EDCs) often exhibit nonmonotonic dose-response (NMDR) relationships, posing significant challenges to health risk assessment and regulations. Several molecular mechanisms operating locally in cells have been proposed, including opposing actions via different receptors, mixed-ligand heterodimer formation, and receptor downregulation. Systemic negative feedback regulation of hormone homeostasis, which is a common feature of many endocrine systems, has also been invoked as a mechanism; however, whether and how exactly such global feedback structure may underpin NMDRs is poorly understood. Objectives: We hypothesize that an EDC may compete with the endogenous hormone for receptors (i) at the central site to interfere with the feedback regulation thus altering the physiological hormone level, and (ii) at the peripheral site to disrupt the hormone action; this dual-action may oppose each other, producing nonmonotonic endocrine effects. The objective here is to explore - through computational modeling - how NMDRs may arise through this potential mechanism and the relevant biological variabilities that enable susceptibility to nonmonotonic effects. Methods: We constructed a dynamical model of a generic hypothalamic-pituitary-endocrine (HPE) axis with negative feedback regulation between a pituitary hormone and a terminal effector hormone (EH). The effects of model parameters, including receptor binding affinities and efficacies, on NMDR were examined for EDC agonists and antagonists. Monte Carlo human population simulations were then conducted to systemically explore biological parameter conditions that engender NMDR. Results: When an EDC interferes sufficiently with the central feedback action of EH, the net endocrine effect at the peripheral target site can be opposite to what is expected of an agonist or antagonist at low concentrations. J/U or Bell-shaped NMDRs arise when the EDC has differential binding affinities and/or efficacies, relative to EH, for the peripheral and central receptors. Quantitative relationships between these biological variabilities and associated distributions were discovered, which can distinguish J/U and Bell-shaped NMDRs from monotonic responses. Conclusions: The ubiquitous negative feedback regulation in endocrine systems can act as a universal mechanism for counterintuitive and nonmonotonic effects of EDCs. Depending on key receptor kinetic and signaling properties of EDCs and endogenous hormones, some individuals may be more susceptible to these complex endocrine effects.

Identification of nonmonotonic concentration-responses in Tox21 high-throughput screening estrogen receptor assays

Quantitative Structure-Activity Relationships of Selected Phenols with Non-Monotonic Dose-Response Curves

Interference with Systemic Negative Feedback Regulation as a Potential Mechanism for Nonmonotonic Dose-Responses of Endocrine-Disrupting Chemicals

Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway

ED Profiler: Machine Learning Tool for Screening Potential Endocrine-Disrupting Chemicals

A novel ERβ high throughput microscopy platform for testing endocrine disrupting chemicals

Structures of Endocrine-Disrupting Chemicals Correlate with the Activation of 12 Classic Nuclear Receptors

Interpretable machine learning for the identification of estrogen receptor agonists, antagonists, and binders

A Novel ERα-mediated Reporter Gene Assay for Screening Estrogenic/antiestrogenic Chemicals Based on LLC-MK2 Cells.

Virtual Screening of Potentially Endocrine-Disrupting Chemicals Against Nuclear Receptors and Its Application to Identify PPARγ-bound Fatty Acids

A Ternary Classification Using Machine Learning Methods of Distinct Estrogen Receptor Activities Within A Large Collection of Environmental Chemicals

Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.

Allosteric binding on nuclear receptors: Insights on screening of non-competitive endocrine-disrupting chemicals

Mechanistic in silico modeling of bisphenols to predict estrogen and glucocorticoid disrupting potentials

Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals Cell Line Specific Responses and Implications for Environmental Screening

An Integrated "4-Phase" Approach for Setting Endocrine Disruption Screening Priorities--phase I and II Predictions of Estrogen Receptor Binding Affinity

Computational Models to Predict Endocrine-Disrupting Chemical Binding with Androgen or Oestrogen Receptors.

Modeling and Insights into the Structural Characteristics of Endocrine-Disrupting Chemicals

Rapid and ultrasensitive detection of endocrine disrupting chemicals using a nanosensor-enabled cell-based platform.

Correction to Structures of Endocrine-Disrupting Chemicals Determine Binding to and Activation of the Estrogen Receptor Α and Androgen Receptor

Identification of Active and Inactive Agonists/antagonists of Estrogen Receptor Based on Tox21 10K Compound Library: Binomial Analysis and Structure Alert.